Updates are available Correction dated 2024-10-07
Click to view Correction: https://doi.org/10.1007/s11095-024-03768-1
-
Authors
Tchessalov, Serguei
Maglio, Vito
Kazarin, Petr https://orcid.org/0000-0003-0063-8509
Alexeenko, Alina
Bhatnagar, Bakul
Sahni, Ekneet
Shalaev, Evgenyi
- License Information
-
More Information
Article History
Received: 20 March 2023
Accepted: 9 September 2023
First Online: 2 October 2023
Change Date: 7 October 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s11095-024-03768-1
Declarations
:
: Serguei Tchessalov<b>:</b> N/A.Vito Maglio: N/A.Petr Kazarin: N/A.Alina Alexeenko: N/A.Bakul Bhatnagar<b>:</b> N/A.Ekneet Sahni: N/A.Evgenyi Shalaev<b>:</b> N/A.
: ES is an employee of AbbVie and may own AbbVie stock. He participated in design of the study, in the collection, analysis, and interpretation of data, and in writing, reviewing, and approval of the final publication. ST, VM, and BB are employees of Pfizer, PK and AA are employees of Purdue University, and Ekneet Sahni is an employee of Regeneron. They do not have any conflicts of interestAbbvie contributed to the design of the study, data collection, analysis and interpretation, manuscript preparation, and approval of the publication; Abbvie did not provide financial support for the study.
